Welcome to our dedicated page for Radnet SEC filings (Ticker: RDNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Medicare reimbursement shifts, equipment leases, and AI software roll-outs make RadNet’s SEC documents a maze for even seasoned analysts. Details on imaging center acquisitions hide in footnotes, while payer-mix tables sprawl across hundreds of pages. If parsing those complexities tests your bandwidth, you’re not alone.
Stock Titan’s AI engine turns each filing into an actionable briefing. Receive real-time alerts the moment a RadNet 8-K material event is posted, skim AI-generated highlights that translate radiology jargon into plain English, and dive into side-by-side redlines that explain how today’s RadNet quarterly earnings report 10-Q filing differs from last quarter’s. Our platform surfaces Form 4 data so you can monitor RadNet insider trading Form 4 transactions and track RadNet executive stock transactions Form 4 in real time. Need the bigger picture? Our summaries of the RadNet annual report 10-K simplified spotlight payer-rate sensitivities, software gross margins, and scan-volume trends—information buried deep in the original PDF.
Whether you’re analysing AI revenue growth, comparing same-center volumes, or checking board compensation targets, you’ll find the answer faster. Use the interactive dashboard to:
- Follow RadNet proxy statement executive compensation metrics without page-count fatigue.
- Set watchlists for RadNet Form 4 insider transactions real-time and spot buying patterns before earnings.
- Export key numbers from each RadNet earnings report filing analysis for your valuation model.
RadNet reported higher second-quarter revenue and a return to quarterly profitability, but a six-month operating loss left common shareholders with a year-to-date deficit. Total service revenue for the three months ended June 30, 2025 was $498,230,000, up from $459,714,000 a year earlier, driven by growth across commercial and Medicare payors. The company recorded quarterly net income of $23,034,000, with net income attributable to RadNet common stockholders of $14,454,000 and diluted EPS of $0.19.
For the six months ended June 30, 2025 RadNet reported a consolidated net loss of $(6,703,000), and a net loss attributable to RadNet common stockholders of $(23,472,000) (diluted EPS $(0.32)). Operating cash flow improved to $161,829,000 for the six months. The company completed acquisitions, including See-Mode Technologies for approximately $28.7 million with contingent consideration of $8.8 million, and goodwill totaled $751,514,000 at June 30, 2025. Total long-term debt was $1,077,251,000.
RadNet, Inc. furnished a press release reporting its financial results for the second quarter ended June 30, 2025, with that press release included as Exhibit 99.1 to this Current Report. The filing identifies the disclosure under Item 2.02 (Results of Operations and Financial Condition) and also includes an interactive XBRL cover page as Exhibit 104. The company states the information is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act and will not be incorporated by reference into other filings except by specific reference.
Aside from the notice that Q2 2025 results were released, the report contains no financial figures, metrics, or commentary on performance. The report was executed on behalf of the registrant by Mark Stolper, Chief Financial Officer, and confirms the company’s common stock trades as RDNT on NASDAQ. Investors must consult Exhibit 99.1 for the detailed Q2 financial results.
RadNet EVP and Chief Science Officer Alma Gregory Sorensen reported a charitable donation of 5,600 shares of common stock on June 17, 2025. The transaction was executed at $0 as it was a gift (Transaction Code: G).
Following the transaction, Sorensen maintains direct beneficial ownership of 1,165,345 shares of RadNet common stock. The filing indicates that Sorensen serves in dual roles as both a Director and Executive Officer (EVP, Chief Science Officer) of the company.
Key Transaction Details:
- Transaction Type: Charitable Donation
- Direct Ownership Maintained
- No derivative securities were involved in this transaction
- Filing was signed by Jose Gamez as Attorney-in-Fact on June 18, 2025
FAQ
What is the current stock price of Radnet (RDNT)?
What is the market cap of Radnet (RDNT)?
